CLINICAL_TRIALS
trial_result
· 2012-02-28
Clinical Trial Update: Efficacy of Pioglitazone on Macrovascular Outcome in Patients With Type 2 Diabetes [Phase 3]
Summary
Phase 3 trial evaluating the efficacy of pioglitazone on macrovascular outcomes in patients with Type 2 diabetes; the study is completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED